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In this issue ofNeuron, Lin et al. (2013) describe InSynC, an optogenetic approach that utilizes chromophore-
assisted light inactivation (CALI) to inactivate presynaptic neurotransmitter release proteins VAMP2 and
synaptophysin. InSynC selectively reduces synaptic transmission in illuminated regions in vitro and in vivo.Optogenetics has revolutionized neuro-
science through the use of heterologously
expressed light-sensitive opsins that are
G protein-coupled receptors, ion chan-
nels, or pumps to stimulate or inhibit activ-
ity in genetically selected neurons and
brain regions, opening exciting avenues
to probe the role of those cells in circuit
function and behavior (Szobota and Isac-
off, 2010; Miesenbo¨ck, 2011; Yizhar et al.,
2011). In addition to naturally light-sensi-
tive opsins used in ‘‘classical’’ optoge-
netics, chemical synthesis combined
with protein engineering has produced
a complementary ‘‘chemical’’ optoge-
netics, or photopharmacology, in which
native mammalian channels, as well as
ionotropic and metabotropic receptors,
can be blocked, agonized, or antagonized
by light, enabling presynaptic or postsyn-
aptic neuronal responses to neurotrans-
mitter release to be selectively controlled
(Kramer et al., 2013; Levitz et al., 2013).
While the optical activation of presynaptic
rhodopsin can partially inhibit transmitter
release during illumination (Li et al.,
2005) and a light-activated metabotropic
glutamate receptor can do so and persist
for many minutes in the dark (Levitz et al.,
2013) and both can be rapidly turned off, a
method for ablation of neurotransmitter
release that lasts for many hours has
beenmissing from the optogenetic quiver.
An exciting first success in the optical
manipulation of the transmitter release
apparatus was developed a decade ago
using chromophore-assisted light inacti-
vation (CALI) (Marek and Davis, 2002).
CALI can be used to selectively inactivate
proteins during excitation of a nearby
chromophore that generates reactive ox-
ygen species (Jay, 1988). Synthetic chro-mophores can be used (Jay, 1988; Marek
and Davis, 2002), turning the tendency of
the fluorophore to enter into a dark triplet
state into something productive by using
it as photosensitizer for exciting oxygen.
To use a synthetic fluorophore in such
an application, it needs to be targeted to
the protein of interest—a challenge in
the complex environment of the cell,
especially in the cytoplasm, where the
transmitter-release apparatus is located.
An elegant solution for protein targeting,
developed by Tsien and coworkers, is to
use biarsenal fluorophores that bind
tightly and specifically to an introduced
tetracysteine sequence (Griffin et al.,
1998). This approach was used success-
fully to target the calcium sensor of trans-
mitter release, synaptotagmin, and
thereby to block synaptic transmission in
Drosophila motor nerve terminals (Marek
and Davis, 2002). However, biarsenal flu-
orophore targeting works well in some
proteins and has been a challenge in
others, despite considerable improve-
ments to the methodology (Hoffmann
et al., 2010). This has led to a search for
other methods by which a singlet
oxygen generator can be targeted to a
specific protein.
The solution seemed to be at hand
when CALI was demonstrated with
genetically encoded chromophores such
as eGFP and KillerRed (Bulina et al.,
2006), suggesting that standard and
highly generalizable fluorescent protein
fusions to the protein target could be
the answer—an even more powerful
strategy because it would be entirely
genetically encoded. But these fluores-
cent protein-based techniques remain
less efficient.NeuronThe solution has nowbeen achieved, as
reported in this issueofNeuronby Lin et al.
(2013), usinganother classof proteinchro-
mophore. The protein to which they turn
is the engineered flavoprotein miniSOG
(singlet oxygen generator). The flavin
mononucleotide that binds to miniSOG
has a higher quantum efficiency for singlet
oxygen photogeneration than GFP or
KillerRed. By analogywith the retinal chro-
mophore of opsins in classical optoge-
netics, flavin mononucleotide is present
naturally at sufficient levels in cells so
that the system depends simply on where
miniSOG is expressed; that is to say,
it is entirely genetically encoded. The
approach was used recently by the group
to kill genetically targeted neurons inCae-
norhabditis elegans (Qi et al., 2012). The
goal now was more refined: to selectively
disable the SNARE proteins of the trans-
mitter release apparatus.
Lin et al. (2013) fused miniSOG to the
SNARE protein VAMP2 (a.k.a. synapto-
brevin2) and the synaptic vesicle protein
synaptophysin with the aim of inactivating
the secretion complex with light. They
demonstrate reduction of synaptic trans-
mission electrophysiologically in hippo-
campal neurons in response to 480 nm
light, which excites the flavin mononucle-
otide. Moreover, they use the styryl dye
FM 4-64 to show that the effect is due
to decreased stimulus-evoked vesicle
cycling, consistent with a block of trans-
mitter release. Importantly, the block
occurs only in illuminated regions, indi-
cating that, beyond the ability to geneti-
cally specify the cell type in which
transmission inactivation occurs via the
cell type-specific expression of the
construct, light patterns can be used to79, July 24, 2013 ª2013 Elsevier Inc. 209
Figure 1. Optical Ablation of Neurotransmitter Release with InSynC
(A) Targeting of miniSOG to a subset of presynaptic inputs (green fibers).
(B) Light-induced singlet oxygen formation inhibits neurotransmitter release at terminals expressing miniSOG at vesicles.
(C) Long-lasting, but reversible, inhibition of neurotransmission at a subset of presynaptic terminals in response to illumination with 480 nm light.
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nals for inactivation.
Taking the system through its paces,
Lin et al. (2013) demonstrate that it works
in organotypic slice from hippocampus,
where the native circuitry is largely pre-
served, and that it works too in vivo
in C. elegans. The experiments in
C. elegans reveal another valuable prop-
erty of the system: recovery. A day after
animals are paralyzed by light they
recover some movement, suggesting
that protein turnover reverses the synap-
tic inactivation. Finally, one does not
need to replace the native gene with the
miniSOG-fused version for the system to
work. It works under conditions of overex-
pression, consistent with prior evidence
that overexpressed VAMP2 and synapto-
physin function in wild-type neurons
where the native copies are present, while
preserving close-to-normal release in the
case of VAMP2, although the overexpres-
sion of synaptophysin can alter release
(Alder et al., 1995; Degtyar et al., 2013).
Since VAMPs and synaptophysin are
broadly used for transmitter release,
these very tools can immediately be
used to inhibit the release of either excit-
atory or inhibitory classical transmitters210 Neuron 79, July 24, 2013 ª2013 Elsevierwith light. One hopes that very soon vari-
ants will be available that target the dense
core vesicle apparatus and the SNARE
proteins of astrocytes to selectively
inactivate peptidergic transmission and
some forms of gliotransmission. At any
rate, the ability to target expression
genetically and aim light should make it
possible to inhibit specific axonal projec-
tions and provide a powerful new option
for circuit dissection (Figure 1).
All good inventions need catchy names
and, through some linguistic calisthenics,
Lin et al. (2013) arrive at a euphonic (but
oy, the capitals!) ‘‘InSynC’’ via the mouth-
ful ‘‘Inhibition of Synapses with CALI,’’
whose ‘‘C,’’ recall, is an acronym of its
own. The results well justify both the
acronym and the decade-long wait.
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